HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suguru Miyaji Selected Research

WEB 2086 (apafant)

8/2004Apafant, a potent platelet-activating factor antagonist, blocks eosinophil activation and is effective in the chronic phase of experimental allergic conjunctivitis in guinea pigs.
8/2003The role of platelet activating factor and the efficacy of apafant ophthalmic solution in experimental allergic conjunctivitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Suguru Miyaji Research Topics

Disease

2Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
08/2004 - 08/2003
1Hypersensitivity (Allergy)
08/2004
1Anaphylaxis (Anaphylactic Shock)
08/2003
1Conjunctivitis
08/2003

Drug/Important Bio-Agent (IBA)

2Platelet Activating FactorIBA
08/2004 - 08/2003
2Ophthalmic Solutions (Eye Drops)IBA
08/2004 - 08/2003
2WEB 2086 (apafant)IBA
08/2004 - 08/2003
1OvalbuminIBA
08/2004
1SolutionsIBA
08/2004
1AntigensIBA
08/2003

Therapy/Procedure

1Ophthalmic Administration
08/2003